Formosa Chemicals & Fibre Corporation (1326.TW)
Taipei, TW
Founded in 1965 and headquartered in Taipei, Taiwan, Formosa Chemicals & Fibre Corporation operates as a multifaceted industrial enterprise with a significant presence both domestically and in international markets. Its primary activities encompass the manufacturing and distribution of a diverse range of petrochemicals, including essential compounds like benzene, para-xylene, and styrene monomer, as well as a variety of plastic products such as polystyrene, ABS resin, and polycarbonate. The company is also a major producer in the textile sector, specializing in nylon fibers, rayon staple fibers, and an extensive selection of specialized yarns, from fireproof and mosaic to multi-blended and ring spun varieties. Beyond its core chemical and fiber businesses, Formosa Chemicals & Fibre maintains a broad portfolio of operations. These include comprehensive textile processing services like spinning, dyeing, printing, and finishing, alongside the production of synthetic fabrics, rugs, and carpets. The corporation is involved in investment activities, energy generation through cogeneration and power plants, and it holds interests in real estate development, rental, and sales. Environmental services, such as waste disposal and spent catalyst recycling, also form part of its scope. Furthermore, the company extends into high-tech manufacturing, covering the research, assembly, and testing of integrated circuits, production of synthetic rubber, industrial catalysts, and battery energy storage systems. Its diverse engagements also encompass the wholesale and retail of chemical and plastic raw materials, international trading, manufacturing and sales of cosmetics and ready-to-wear apparel, provision of employment services, and the planning, design, and installation of LED lighting systems.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.33% | -9.80% | -17.40% | +4.28% | +32.65% | +40.50% | +73.46% | -33.48% | -45.60% | -44.25% | +162.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-17.7% Q1'26: +3.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-1,625.4% Q1'26: +1,517.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.7% ★ Q1'26: -5.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.4% Q1'26: +3.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%-1.0% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×11.70× Q1'26: 4.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
329.35B
est: 329.32B (+0.0%)
|
319.20B
est: 320.87B (-0.5%)
|
358.42B
est: 356.69B (+0.5%)
|
407.86B
est: 407.56B (+0.1%)
|
315.50B
est: 332.63B (-5.1%)
|
253.29B
est: 253.30B (0.0%)
|
365.81B
est: 363.60B (+0.6%)
|
379.90B
est: 386.74B (-1.8%)
|
332.62B
est: 354.84B (-6.3%)
|
348.61B
est: 347.10B (+0.4%)
|
287.03B
est: 295.25B (-2.8%)
|
303.54B
291.01B – 324.10B
+2.8% YoY
|
308.23B
270.12B – 322.62B
+1.5% YoY
|
327.65B
327.65B – 327.65B
+6.3% YoY
|
| EBITDA |
39.32B
est: 32.94B (+19.4%)
|
53.78B
est: 32.10B (+67.5%)
|
86.86B
est: 35.68B (+143.4%)
|
66.57B
est: 40.77B (+63.3%)
|
57.42B
est: 33.27B (+72.6%)
|
32.15B
est: 25.34B (+26.9%)
|
56.63B
est: 36.37B (+55.7%)
|
29.85B
est: 38.69B (-22.8%)
|
27.87B
est: 29.20B (-4.6%)
|
19.54B
est: 28.57B (-31.6%)
|
10.99B
est: 24.30B (-54.8%)
|
24.98B
23.95B – 26.67B
+2.8% YoY
|
25.37B
22.23B – 26.55B
+1.5% YoY
|
26.97B
26.97B – 26.97B
+6.3% YoY
|
| EBIT |
38.29B
est: 15.74B (+143.2%)
|
56.67B
est: 15.34B (+269.4%)
|
38.91B
est: 17.05B (+128.2%)
|
48.91B
est: 19.48B (+151.0%)
|
29.73B
est: 15.90B (+86.9%)
|
15.32B
est: 12.11B (+26.5%)
|
34.43B
est: 17.38B (+98.1%)
|
11.39B
est: 18.49B (-38.4%)
|
10.41B
est: 11.73B (-11.3%)
|
4.35B
est: 11.47B (-62.1%)
|
-4.04B
est: 9.76B (-141.4%)
|
10.03B
9.62B – 10.71B
+2.8% YoY
|
10.19B
8.93B – 10.66B
+1.5% YoY
|
10.83B
10.83B – 10.83B
+6.3% YoY
|
| Net Income |
27.58B
est: 27.60B (-0.1%)
|
43.83B
est: 42.66B (+2.8%)
|
54.41B
est: 53.70B (+1.3%)
|
48.77B
est: 49.66B (-1.8%)
|
29.70B
est: 31.00B (-4.2%)
|
19.54B
est: 19.50B (+0.2%)
|
38.36B
est: 40.11B (-4.4%)
|
7.36B
est: 9.61B (-23.4%)
|
8.55B
est: 10.98B (-22.2%)
|
379.41M
est: 391.69M (-3.1%)
|
-5.80B
est: -4.78B (-21.4%)
|
14.00B
7.99B – 14.58B
+393.1% YoY
|
11.62B
5.11B – 13.04B
-17.0% YoY
|
23.60B
21.01B – 25.30B
+103.1% YoY
|
| SGA |
14.34B
est: 16.06B (-10.7%)
|
14.12B
est: 15.65B (-9.8%)
|
14.28B
est: 17.39B (-17.9%)
|
15.22B
est: 19.87B (-23.4%)
|
15.57B
est: 16.22B (-4.0%)
|
14.21B
est: 12.35B (+15.0%)
|
19.01B
est: 17.73B (+7.2%)
|
18.03B
est: 18.86B (-4.4%)
|
14.47B
est: 16.63B (-12.9%)
|
15.61B
est: 16.26B (-4.0%)
|
13.37B
est: 13.83B (-3.4%)
|
14.22B
13.64B – 15.19B
+2.8% YoY
|
14.44B
12.66B – 15.12B
+1.5% YoY
|
15.35B
15.35B – 15.35B
+6.3% YoY
|
| EPS |
4.72
est: 4.72 (+0.0%)
|
7.50
est: 7.29 (+2.8%)
|
9.33
est: 9.18 (+1.6%)
|
8.36
est: 8.49 (-1.5%)
|
5.09
est: 5.30 (-4.0%)
|
3.34
est: 3.33 (+0.2%)
|
6.56
est: 6.86 (-4.3%)
|
1.26
est: 1.64 (-23.3%)
|
1.46
est: 1.88 (-22.2%)
|
0.06
est: 0.07 (-4.7%)
|
-0.99
est: -0.83 (-19.2%)
|
1.94
1.37 – 2.49
+333.9% YoY
|
1.71
0.87 – 2.23
-11.8% YoY
|
4.03
3.59 – 4.32
+135.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Taiwan ETF EWT | 0.56% | 60.11M | 0.59% |
| 2 | Schwab Fundamental Emerging Markets Large Company Index ETF FNDE | 0.32% | 29.99M | 0.39% |
| 3 | HSBC ETFs Public Limited Company - HSBC MSCI Taiwan UCITS ETF HTWN.L | 0.31% | 336.1K | 0.50% |
| 4 | Franklin FTSE Taiwan ETF FLTW | 0.30% | 8.98M | 0.19% |
| 5 | iShares MSCI Taiwan UCITS ETF IDTW.L | 0.30% | 4.67M | 0.74% |
| 6 | Xtrackers MSCI Taiwan UCITS ETF 1C XMTD.L | 0.28% | 1.33M | 0.65% |
| 7 | Franklin FTSE Taiwan UCITS ETF FLXT.MI | 0.27% | 1.78M | 0.19% |
| 8 | Invesco FTSE RAFI Emerging Markets UCITS ETF PSRM.L | 0.19% | 156.4K | 0.49% |
| 9 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.15% | 666.6K | 0.49% |
| 10 | iShares MSCI EM Islamic UCITS ETF ISDE.L | 0.15% | 1.13M | 0.35% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chia Ju Liu | Financial Officer & Corporate Governance Officer | — | male |
| Ching Fen Lee | Executive Vice President & Director | — | male |
| Fu-Yuan Hong | MD & Chairman | — | male |
| Ruey-Long Chen | MD & Director | — | male |
| Ruey-Yu Wang | MD & Director | — | female |
| Wei Keng Chien | Senior Vice President & Director | — | male |
| Wen Chìn Lu | President & Director | — | male |
| Wen Yen Cheng | Accounting Officer | — | male |
| Wen-Chiao Wang | MD & Director | — | male |
| Weng Tsao Wang | Managing Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1326.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
